VXRT: Vaxart, Inc Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 837.44
Enterprise Value ($M) 873.56
Book Value ($M) 40.23
Book Value / Share 0.37
Price / Book 21.71
NCAV ($M) 21.77
NCAV / Share 0.20
Price / NCAV 40.13

Profitability (mra)
Return on Invested Capital (ROIC) -1.44
Return on Assets (ROA) -0.53
Return on Equity (ROE) -1.66

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 3.98

Balance Sheet (mrq) ($M)
Current Assets 45.73
Assets 64.19
Liabilities 23.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.79
Net Income -18.64
Earnings Per Share Basic And Diluted -0.86
Earnings Per Share Diluted -0.86
Earnings Per Share Basic -0.86

Cash Flow Statement (mra) ($M)
Cash From Operations -13.09
Cash from Investing -0.85
Cash from Financing -0.85

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-06-30 13D/A Armistice Capital, Llc 0.20 -99.13
2020-02-11 13G/A BML Investment Partners, L.P. 3.50 85.88
2020-01-08 13G/A Sabby Management, Llc 4.99 229.25
2018-02-23 13D Care Capital III LLC 39.40
2018-02-15 13G Krensavage Asset Management, LLC 7.27
2018-02-14 13G East Hill Management Company, Llc 8.30 -5.92
2018-02-13 13G/A Broadfin Capital, LLC 0.00 -100.00
2018-02-13 13D/A Digirad Corp 8.30 0.00
2018-01-18 13D/A SC Fundamental Value Fund, L.P. 4.83 -23.12
2017-02-13 13G/A Senzar Asset Management, Llc 4.60
2016-02-10 13G/A Clay Landon T 8.80
2014-02-05 13G State Street Corp 0.10
2013-12-06 13G/A Hunter Hall Investment Management LTD 3.56
2013-11-14 13G/A Mangrove Partners Fund, L.p. 0.00
2013-02-15 13D/A Xstelos Holdings, Inc. 1.30
2013-02-12 13G/A Renaissance Technologies Llc 1.08
2013-02-12 13G/A Vanguard Group Inc
2012-11-20 13D/A Gamco Investors, Inc. Et Al 0.95
2012-07-11 13G/A BlackRock Inc. 2.27
2012-02-14 13G/A Costa Brava Partnership III LP 0.60
2012-01-13 13D/A 683 Capital Management, LLC 4.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-08-06 10-Q Quarterly Report – FORM 10-Q
2020-05-12 10-Q The Registrant’s Quarterly Report on Form 10-Q, filed with the SEC on May 12, 2020
2020-03-19 10-K The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 19, 2020

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-12-01 5,071,031 16,648,800 30.46
2020-11-30 5,117,309 25,497,024 20.07
2020-11-27 1,753,912 9,710,067 18.06

(click for more detail)

Similar Companies
VTRS – Viatris Inc. VTVT – vTv Therapeutics Inc
VVUS – VIVUS, Inc. VYGR – Voyager Therapeutics, Inc
VYNE – VYNE Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io